Gilead Sciences, Inc. (GILD), based in Foster City, California, is a leading biopharmaceutical company focused on developing and commercializing groundbreaking therapies for diseases like HIV, liver ...
Situated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the development and commercialization of innovative therapies for diseases such as ...
Gilead Sciences’ (NASDAQ:GILD) Q2 earnings are scheduled to be released on August 7, after market close. The pharma company is expected to post an EPS of $1.96, a 2.5% decline from the year-ago ...
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what you need to know. Gilead Sciences beat analysts’ revenue expectations by 6.3 ...
Science is taking over UCSF’s Mission Bay campus later this month, and everyone’s invited. After a three-year break, the Bay Area Science Festival, Northern California’s largest free science ...
Zoetis, Inc. ZTS is expected to beat expectations when it reports its third-quarter 2025 earnings on Nov. 4, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported ...